Paul Beninger, MD, MBA
Co-Editor-in-Chief
Assistant Professor of Public Health and Community Medicine
Tufts University School of Medicine, Boston, MA
Senior Medical Advisor in Global Pharmacovigilance and Epidemiology
Sanofi, Cambridge, MA

Dr. Beninger is Senior Medical Advisor in Global Pharmacovigilance and Epidemiology at Sanofi, in Cambridge, Massachusetts, where he is the manager of the Center of Excellence for due diligence activities and policy.

He began his career in drug development in 1987 at the US Food and Drug Administration, first as a reviewer and manager for drugs against HIV/AIDS and opportunistic infections and then as a division director for medical devices. He joined Merck & Company in 1995 and developed experience in regulatory affairs, medical services and drug safety in the areas of anti-infective drug and biological products, vaccines, anti-diabetic drug products and oncology drug products, before joining Genzyme as vice-president of pharmacovigilance in 2006; Genzyme was acquired by Sanofi in 2011.

Dr Beninger trained in internal medicine and infectious diseases. He received his MD from the University of California, Davis, his BA from Claremont McKenna College in Claremont, California, his MBA from St Joseph’s University in Philadelphia, Pennsylvania, and his graduate certificate in epidemiology from Tufts University in Boston, Massachusetts. He has published and spoken extensively on regulatory science, drug and medical device safety, and pharmacovigilance, and he is a fellow of the American College of Physicians and the Infectious Disease Society of America.

He is also an Assistant Professor of Public Health and Community Medicine at Tufts University School of Medicine and Director of the MD/MBA and MBS/MBA Programs.

Advertisement